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Abstract

Introduction: For patients with clinically localized renal masses, positive surgical margins (PSMs) after robotic
partial nephrectomy (RPN) have been associated with a higher risk of disease recurrence, although some studies
have challenged this conclusion. Owing to inconsistent reports and a lack of long-term robotic data, the clinical
impact of PSM after RPN remains uncertain. We evaluate long-term (>6 years) survival outcomes after RPN in
patients with clinically localized disease with respect to surgical margin status.
Methods: We conducted a retrospective review of patients who underwent RPN for clinically localized renal
masses from June 2007 to December 2012 at Washington University School of Medicine. Disease recurrence
and overall survival (OS) were stratified on the presence or absence of PSM. The cohort was analyzed to
identify patient- and tumor-specific characteristics associated with PSM.
Results: We identified 374 RPNs performed from 2007 to 2012 with a mean follow-up time of 77.7 months
(SD 32.2 months). PSM was identified in 12 (3.2%) patients. Patients with PSM were at 14-fold increased risk
for recurrence with no difference in OS ( p < 0.001, p = 0.130, respectively). Patients with PSM had higher
incidence of chronic obstructive pulmonary disease (COPD) (25% vs 6.4%) and greater blood loss (425 mL vs
203 mL).
Conclusion: With an extended follow-up period of 77 months after RPN, we found that PSM substantially
increased the risk of recurrence without impacting OS. Our finding that PSM may occur more frequently in
older patients with COPD must be confirmed in larger studies.
Keywords: renal cell carcinoma, surgical margins, nephrectomy, robotic surgery, follow-up
Introduction

I

n the early 2000s, robotic partial nephrectomy (RPN)
was increasingly adopted by urologic surgeons in the United
States.1 Today, RPN is now widely utilized as what most would
advocate as the standard of care for the treatment of localized
renal masses. The superiority of RPN over open and laparoscopic approaches for the appropriately selected renal masses
is supported by robust data citing decreased intraoperative
morbidity, shorter hospital stay, and reduced complications
while maintaining efficacious oncologic control.2–4 However,
although positive surgical margin (PSM) status appears to be
similar across approaches, hesitancy still exists when encountering PSM after the robotic approach.5–7 The clinical impact
of PSM after RPN is debated across the literature with the longterm implications of PSM yet to be determined.

Intermediate-term studies have identified PSM after partial
nephrectomy as a risk factor for recurrence, but this interpretation is unclear as open and laparoscopic approaches
were also included in the analysis.4,8,9 As follow-up for robotic cases becomes available, studies focusing on RPNs
have shown conflicting evidence that PSM leads to locoregional recurrence.10,11 In 2013, Khalifeh et al. published a
multi-institutional study associating PSM with recurrence
rates, reporting a hazard ratio (HR) of 18 for recurrence
among patients with PSM at 17.3 months follow-up.12 Another study by Shah and colleagues reported a recurrence rate
of 5.6% among all patients undergoing RPN for a localized
renal mass and found PSM to be associated with recurrence
for high-risk disease (Fuhrman grade III–IV and >pT2) at a
follow-up of 33 months.13 Contradicting results were found
in a 2019 multi-institutional study of 839 patients undergoing
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RPNs that showed no association between PSM and oncologic outcomes, with a median follow-up for recurrence of
13.1 months.14 None of these studies found an effect on
survival. Few studies have analyzed a follow-up period of 2
years or greater, thus providing an agenda for future study to
determine the long-term oncologic and survival implications
of PSM after RPN.12,13,15
Herein, we report our institution’s experience with longterm oncologic and survival outcomes after RPN based on
surgical margin status. We evaluated follow-up of >6 years at
our tertiary referral center to elucidate long-term outcomes in
these patients. We hypothesized that higher recurrence rates
would be seen among patients with PSM, who are presumed
to have residual tumor. We also hypothesized that with longterm follow-up, overall survival (OS) would be worse for
patients with PSM.
Methods

IRB approval for this project was obtained through the
Washington University Human Research Protection Office
before study initiation. We conducted a retrospective review
from a prospectively maintained database of all patients who
underwent RPN for a clinically localized renal mass with
malignant surgical pathology from June 2007 to December
2012 at Washington University School of Medicine. This
5-year period represented our initial RPN experience and thus
included the experience of our surgeons’ learning curve with
the robotic platform. Patients with bilateral or multiple tumors were excluded from our analysis. The cohort was
compared across patient- and tumor-specific characteristics.
Follow-up assessment was done by review of urology or
oncology progress notes and surveillance imaging (computed
tomography or MRI).
Descriptive statistics of patient, tumor, and surgical characteristics were reported. Wilcoxon sum-rank tests and
Fisher’s exact test were used to test for associations between
PSM and quantitative and qualitative variables of interest.
We also tested for associations between PSM and variables of
interest after performing 4:1 propensity matching based on
age, Charlson Comorbidity Index (CCI), tumor size, histologic subtype, and Fuhrman grade. Kaplan–Meier curves
using the log rank test were used to test for associations
between qualitative variables of interest and both OS and
disease-free survival (DFS), both with and without matching.
Matched results are available in the supplemental materials.
Statistical significance was set to p < 0.05. All analyses were
performed using Rv3.5.2.16
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assessed. Fuhrman grade breakdown included 268 (71.7%)
tumors comprising grades I to II, and 82 (21.9%) comprising
grades III to IV, whereas Fuhrman grade could not be assessed for 24 patients (6.4%). See Table 1 for full description
of patient and tumor characteristics. Margin depth was not
routinely reported. Tumor enucleation was rarely performed.
Factors impacting PSM

PSM was found in 12 patients (3.2%). Patients with PSM
had higher incidence of chronic obstructive pulmonary disease (COPD) (25% vs 6.4%, p = 0.043) and were older (66.1
years vs 57.4 years, p = 0.022) than patients with negative
surgical margins (Table 2). Patients with PSM also had
greater estimated blood loss than patients without PSM
(425 mL vs 203 mL, p = 0.007). All other operative- and
tumor-specific characteristics were equivalent between
groups, including nephrometry score, operative time, and
Fuhrman grade ( p = 0.23, p = 0.15, p = 0.69, respectively).
Clinical and follow-up details of patients with PSM are
provided in Table 3.

Table 1. Summary of Patient, Tumor,
and Surgical Characteristics
Variable
Age
Gender
BMI
CCI

pT stage

Fuhrman grade

Histologic subtype
Tumor size (clinical)

Results

Laterality

From 2007 to 2012, we identified 409 RPNs at our institution. Thirty-five patients were excluded for having bilateral or multiple renal masses, resulting in 374 patients for
analysis. The average age for all patients was 57.7 years
(SD 12.4), with 165 females and 209 males. The average
body mass index was 31.1 kg/m2 (SD 7.2). Mean follow-up
time was 77.7 months (SD 32.2 months).
The mean clinical tumor size was 3.1 cm (SD 1.4 cm). The
mean RENAL nephrometry score was 7.6 (1.7) among 293
(78.3%) patients for whom this could be assessed. Of all renal
masses, 363 (97.0%) were pT1a-b and 10 (2.7%) were pT2 or
greater, with one patient for whom pT stage could not be

RENAL nephrometry score
Operative time
Estimated blood loss
Off-clamp
Pelvicaliceal repair

Statistic

n = 374

Mean
SD
Female
Male
Mean
SD
0
1
2
3
‡4
1a
1b
2a, 2b, 3a
Missing
I
II
III, IV
Missing
Clear cell
Papillary
Other
Mean
SD
Right
Left
Mean
SD
Missing
Mean
SD
Mean
SD
No
Yes
No
Yes

57.7
12.4
165
209
31.1
7.2
188
69
64
29
24
317
46
10
1
53
215
82
24
278
64
32
3.1
1.4
179
195
7.6
1.7
81
160.1
50.1
210
267
295
77
297
77

BMI = body mass index; CCI = Charlson Comorbidity Index.

Table 2. Comparison of Patient, Tumor, and Surgical Characteristics Between Patients
With and Without Positive Surgical Margin
Variable
Age
Gender
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BMI
CCI

COPD
DM
pT stage
Fuhrman grade
Histologic subtype
Tumor size (clinical)
Laterality
RENAL nephrometry score
Operative time
EBL
Off-clamp
Pelvicaliceal repair

Statistic

PSM = No (362)

PSM = Yes (12)

p-Value

Mean
SD
Female
Male
Mean
SD
0 (188)
1 (69)
2 (64)
3 (29)
‡4 (24)
No (348)
Yes (26)
No (292)
Yes (82)
1a
1b
2a,2b,3a
I
II
III, IV
Clear cell (278)
Papillary (64)
Other (32)
Mean
SD
Right
Left
Mean
SD
Missing
Mean
SD
Mean
SD
No
Yes
No
Yes

57.4
12.4
43.9%
56.1%
31.1
7.1
50.8%
17.7%
16.9%
8.0%
6.6%
93.6%
6.4%
78.5%
21.5%
85.0%
12.2%
2.8%
15.4%
61.5%
23.1%
74.6%
17.1%
8.3%
3.1
1.4
48.1%
51.9%
7.5
1.7
77
159.6
50.5
203
251
79.0%
21.0%
44.2%
55.8%

66.1
10.2
50.0%
50.0%
31.5
9.6
33.3%
41.7%
25.0%
0.0%
0.0%
75.0%
25.0%
66.7%
33.3%
83.3%
16.7%
0.0%
8.3%
58.3%
33.3%
66.7%
16.7%
16.7%
3.0
1.0
41.7%
58.3%
8.3
1.3
4
173.4
33.8
425
555
91.7%
8.3%
58.3%
41.7%

0.022
0.677
0.715
0.218

0.043
0.305
0.752
0.693
0.447
0.728
0.662
0.225
0.150
0.007
0.472
0.333

Bold values indicate p < 0.05.
COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; EBL = estimated blood loss.

Table 3. Follow-Up Details of Patients with Positive Surgical Margins
Follow-up (months)
7.2
17.7
20.3
23.4
70.2
74
78.1
86
89.1
106.1
124.8
136.8

Vascular clamping

Margin description

Recurrence

Death

Yes
Yes
Yes
No
Yes
Yes
Yes
No
Yes
No
Yes
Yes

‘‘Carcinoma extends to resection margin.’’
‘‘Tumor focally present at inked margin.’’
‘‘Carcinoma focally extends to resection margin.’’
‘‘Carcinoma approaches surgical margin.’’
‘‘Carcinoma present at cauterized margin.’’
‘‘Tumor is near the inked surface.’’
‘‘Tumor extends to inked margin of excision.’’
‘‘Carcinoma abuts cauterized margin.’’
‘‘Tumor extends to inked margin of excision.’’
‘‘Tumor extends to excision margin.’’
‘‘Tumor present at deep margin.’’
‘‘Inked peripheral margin is positive for carcinoma.’’

No
No
Yes
No
No
No
No
Yes
No
Yes
No
No

Yes
No
Yes
Yes
No
No
No
No
No
No
No
No

All n = 12 patients had grossly negative margins per the operative report.
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FIG. 1.
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Comparison of overall survival and disease-free survival based on PSM. PSM, positive surgical margin.

Impact of tumor and patient characteristics on survival

Patients with PSM were at substantially heightened risk for
disease recurrence compared with patients without PSM,
with a HR for DFS of 14.6 (95% confidence interval [CI] 3.9–
55.1) (Fig. 1). There was no statistically significant difference
in OS between the two groups ( p = 0.13), but a visual difference in OS was observed with patients with PSM dying
earlier than patients without PSM. Over the follow-up period,
46 patients (12.3%) died and 11 (2.9%) experienced disease
recurrence in total. Clinical details of patients who experienced recurrence are given in Table 4. Three of the 11 patients who experienced disease recurrence had PSM. All
recurrences were locoregional except for one patient without
PSM who had a distant metastasis to the bone at 69 months
after RPN.
In our analysis, DFS was not impacted by tumor characteristics including pT stage ( p = 0.578), histologic subtype
( p = 0.482), or tumor grade ( p = 0.245). OS was not impacted
by pT stage ( p = 0.076), histologic subtype ( p = 0.811), or
tumor grade ( p = 0.222). OS was significantly worse in pa-

tients with age >60 years, higher CCI, and presence of COPD
( p < 0.001). The only patient characteristic that impacted
DFS was age >60 years ( p < 0.001).
Finally, owing to the large proportion of patients with
negative margins, we performed a sensitivity analysis by
matching patients with PSM 4:1 based on age, CCI, tumor
size, histologic subtype, and Fuhrman grade (Supplementary
Tables S1 and S2). Under this analysis, we found that blood
loss was still significantly associated with PSM ( p = 0.002).
The relationship between PSM and recurrence risk was robust to this analysis, with a HR for DFS equal to 7.8 (95% CI
1.3–46.8) ( p = 0.008). OS was worse for high-grade tumors,
with an HR of 4.0 (1.0–16.2) ( p = 0.034), but not for PSM or
large tumors ( p = 0.177, p = 0.639, respectively).
Discussion

Following the principles of surgical oncology, the goal of
RPN is to achieve negative surgical margins, while preserving
renal function when possible. In our single-center analysis of

Table 4. Individual Recurrence Location, Time, Margin Status, and Management
Recurrence

Time to recurrence

Surgical margin

Management

Local
Local
Local
Local
Local
Local
Local
Local
Local
Metastatic
Local

7 months after RPN
14 months after RPN
16 months after RPN
19 months after RPN
21 months after RPN
22 months after RPN
35 months after RPN
46 months after RPN
60 months after RPN
69 months after RPN
88 months after RPN

Positive
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Positive
Negative
Positive

Completion nephrectomy (alive)
Unknown (alive)
Cryoablation (deceased)
Repeat partial nephrectomy (deceased)
Repeat partial nephrectomy (alive)
Cryoablation (alive)
Repeat partial nephrectomy (alive)
Cryoablation · 2 (alive)
Observation (alive)
Observation (alive)
Repeat partial nephrectomy (alive)

RPN = robotic partial nephrectomy.
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PSM after RPN with follow-up of 77.7 months, we found that
positive margins were associated with a substantially higher
recurrence rate without an impact on OS. Our institution
adopted our first da Vinci S Surgical System (Intuitive Surgical, Sunnyvale, CA) in 2007. This analysis, therefore, included our initial 5-year experience with RPN. Our incidence
of PSM after RPN (3.2%) was compatible with estimates from
a recent meta-analysis citing an average of 3.9%.4 These data
provide optimistic findings that in the midst of our surgical
learning curve, our experience with RPN has provided a low
rate of PSM. However, as previous studies have indicated,
these patients were at substantially higher risk for recurrence.
Impact of tumor and patient characteristics on survival

With our long-term follow-up, we found that patients with
PSM had a HR of recurrence of 14.6 (95% CI 3.9–55.1,
p < 0.001) compared with patients without PSM. However,
PSM did not impact OS in the study period. High-grade
histology and cancer subtype did not impact DFS or OS.
These results agree with several shorter studies that found
PSM to be related with disease recurrence, but not survival, 2
to 3 years after RPN.12,17,18 Shah et al. reported a HR of
recurrence of 2.08 (1.09–3.97) for patients with PSM after
RPN.13 Khalifeh and colleagues reported a HR of recurrence
of 18.4 (2.27–110.8) among patients with PSM, including a
subset of patients in our study as well.12 Our estimate for the
HR of recurrence falls in the range of previous studies, and
together, these results indicate that patients with PSM after
RPN require closer surveillance as they are at substantially
higher risk for recurrence. Our study also emphasizes the
importance of extended follow-up in these patients, as two
patients with PSM experienced recurrence 5 or more years
after RPN. Current American Urologic Association guidelines indicate that screening for recurrence beyond 5 years is
optional even in moderate- to high-risk patients.19 However,
our results add to retrospective data showing that even with
5 years of surveillance, up to a third of recurrences may be
missed.20 These data indicate that follow-up must be extended in these patients to mitigate the risk of adverse oncologic outcomes associated with PSM.
In addition to our extended follow-up period, one major
strength of our study is our patient selection, particularly when
compared with prior studies. Our study had a restrictive inclusion of high-risk tumor features that are innately at higher
risk for tumor recurrence. In our early experience while overcoming the surgical learning curve, our institution was more
selective in performing RPN for tumors of advanced clinical
stage, with only 10 patients (2.7%) having pT2 or greater tumors in our population, compared with 5.0% in the larger study
by Khalifeh and colleagues study.12 We also found a lower
percentage of high-grade tumors (21.9%) than their study
(40.9%). Furthermore, our study excluded patients with a
propensity for multifocal tumorgenicity such as those with bilateral and multiple tumors. This was intentional in our analysis
as we aimed to focus on recurrence as it relates to surgical
margin status rather than because of oncogenic potentiation of a
satellite region. By filtering out these high-risk tumor features,
our study provides a more focused analysis on surgical margin
for the individual with a solitary localized tumor after RPN. We
believe that this is a critical distinction when interpreting recurrence based on PSM, particularly when a majority of RPNs
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fall in the setting of a solitary renal mass. Our report indicates
that PSM may significantly increase long-term recurrence risk
after RPN, even for a low-risk patient with a solitary tumor. It is
important to note that most patients in our study who recurred
underwent secondary intervention. Therefore, although OS was
equivalent between groups, this finding must be interpreted in
the context of our retrospective design, and the risk of adverse
outcomes in patients with PSM cannot be downplayed.
Evidence from historical open literature has indicated that
patients with PSM do not necessarily require immediate intervention but rather can be managed with close surveillance
imaging.14,21,22 One study looking at reresection and completion nephrectomy found only 6% of initial PSM after open
partial nephrectomy had residual tumor on the second surgical
specimen.22 However, our results add to ongoing studies
showing that patients with PSM require close surveillance
because of the heightened risk of local recurrence.4,10,14,23
Factors impacting PSM

Our study found that patients with PSM had equivalent
nephrometry scores to patients without PSM. We found
similar rates of pelvicaliceal repair, off-clamp technique, and
operative time between these groups. Patients with PSM,
however, had greater blood loss (425 mL vs 203 mL,
p = 0.007) than patients without PSM. Although PSM does
not appear to correlate with preoperative assessment scales,
this finding may reflect anatomical or technical complexity of
these cases, which is not captured by the RENAL nephrometry score. Such potential variables include the presence of adherent perirenal fat, pathologic hypervascularity,
or aberrant vasculature, making the procedure more complicated with increased risk of bleeding.24 These unfavorable
tumor factors and associated bleeding risk can obscure observation of tumor margins during resection and predispose
these patients to PSM.
Our analysis found that those who had PSM were *10
years older and had a fourfold higher risk of having COPD.
These findings could reflect the difficulty of ventilatory
management in this patient population who are at risk of
hypercarbia with maintenance of pneumoperitoneum.25 In
such cases, lowering the pneumoperitoneum can assist in
decreasing CO2 absorption, at the cost of poor visibility and
increased bleeding with tumor excision. This interpretation is
supported by our higher volume of estimated blood loss in
patients with PSM despite there being no difference in tumor
complexity when compared with patients with negative surgical margins. We routinely insufflate to a pressure of 15 mm
Hg for our RPN, although data on modifications of insufflation pressures were not available in the charts of patients with
COPD. Thus, we suspect that older patients with chronic
respiratory disease may be at higher risk of PSM, but this
potential risk must be balanced with appropriate ventilatory
management during surgery. This finding must be confirmed
with larger studies.
There are several limitations to this study including the
potential for selection bias owing to our retrospective design.
Most patients who experienced recurrence underwent retreatment, limiting our analysis of OS. Our small sample size
may also limit conclusions about the impact of PSM on OS.
As a tertiary referral center, we do not have access to patient’s
external charts, and thus analysis of other factors impacting

IMPACT OF MARGIN STATUS ON SURVIVAL AFTER RPN

survival is limited. Our experience also primarily reflects the
proficiency of three high-volume surgeons utilizing surgeonspecific techniques with 20.6% performed using our offclamp RPN technique.26 Thus, one can assume that there are
varying techniques performed and it may be difficult to
generalize our findings to other clinical settings.
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Conclusion

PSM after RPN for a solitary renal tumor at our institution
occurred in 3.2% of patients. Our extended follow-up period
of 77 months found a substantial impact of PSM on likelihood of recurrence after RPN. Our finding that PSM may
occur more frequently in older patients with COPD must be
confirmed in larger studies.
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